• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发性与晚发性阿尔茨海默病认知衰退和皮质萎缩相关因素的异质性。

Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer's disease.

机构信息

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea.

出版信息

Sci Rep. 2024 Sep 3;14(1):20429. doi: 10.1038/s41598-024-71402-6.

DOI:10.1038/s41598-024-71402-6
PMID:39227668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11372067/
Abstract

The objectives of this study were to investigate the variable factors associated with cognitive function and cortical atrophy and estimated variable importance of those factors in affecting cognitive function and cortical atrophy in patients with EOAD and LOAD. Patients with EOAD (n = 40), LOAD (n = 34), and healthy volunteers with normal cognition were included (n = 65). All of them performed 3T MRI, [F]THK5351 PET (THK), [F]flutemetamol PET (FLUTE), and detailed neuropsychological tests. To investigate factors associated with neuropsychological test results and cortical thickness in each group, we conducted multivariable linear regression models, including amyloid, tau, cerebral small vessel disease markers on MRI, and vascular risk factors. Then, we estimated variable importance in associating cognitive functions and cortical thickness, using relative importance analysis. In patients with EOAD, global THK retention was the most important contributor to the model variances for most neuropsychological tests, except for memory. However, in patients with LOAD, multiple contributors beyond tau were important in explaining variance of neuropsychological tests. In analyses with mean cortical thickness, global THK retention was the main contributor in patients with EOAD, while in LOAD patients, multiple factors contributed equally to mean cortical thickness. Therefore, EOAD and LOAD may have different pathomechanistic courses.

摘要

本研究的目的是探讨与认知功能和皮质萎缩相关的可变因素,并评估这些因素对 EOAD 和 LOAD 患者认知功能和皮质萎缩的影响的重要性。纳入了 EOAD 患者(n=40)、LOAD 患者(n=34)和认知正常的健康志愿者(n=65)。所有患者均进行了 3T MRI、[F]THK5351 PET(THK)、[F]flutemetamol PET(FLUTE)和详细的神经心理学测试。为了研究每个组中与神经心理学测试结果和皮质厚度相关的因素,我们进行了多变量线性回归模型,包括 MRI 上的淀粉样蛋白、tau、脑小血管疾病标志物和血管危险因素。然后,我们使用相对重要性分析来估计与认知功能和皮质厚度相关的变量的重要性。在 EOAD 患者中,除了记忆之外,大多数神经心理学测试的模型方差中,全局 THK 保留是最重要的贡献者。然而,在 LOAD 患者中,tau 以外的多个因素对于解释神经心理学测试的方差很重要。在平均皮质厚度的分析中,全局 THK 保留是 EOAD 患者的主要贡献者,而在 LOAD 患者中,多个因素对平均皮质厚度的贡献相等。因此,EOAD 和 LOAD 可能具有不同的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/d90a2668d67a/41598_2024_71402_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/7892d9c0c81b/41598_2024_71402_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/ed96cade5aa1/41598_2024_71402_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/d90a2668d67a/41598_2024_71402_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/7892d9c0c81b/41598_2024_71402_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/ed96cade5aa1/41598_2024_71402_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c9/11372067/d90a2668d67a/41598_2024_71402_Fig3_HTML.jpg

相似文献

1
Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer's disease.早发性与晚发性阿尔茨海默病认知衰退和皮质萎缩相关因素的异质性。
Sci Rep. 2024 Sep 3;14(1):20429. doi: 10.1038/s41598-024-71402-6.
2
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts.早发型和晚发型阿尔茨海默病皮质萎缩的可分离空间地形学:LEADS和ADNI队列的直接比较。
Alzheimers Dement. 2025 Feb;21(2):e14489. doi: 10.1002/alz.14489. Epub 2025 Feb 19.
3
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach.散发性早发型阿尔茨海默病的异质性临床表型:一种基于神经心理学数据驱动的方法。
Alzheimers Res Ther. 2025 Feb 6;17(1):38. doi: 10.1186/s13195-025-01689-8.
4
Diverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.早发性和晚发性阿尔茨海默病中淀粉样蛋白、tau 和脑萎缩之间的关系存在差异。
Yonsei Med J. 2024 Aug;65(8):434-447. doi: 10.3349/ymj.2023.0308.
5
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
6
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
7
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
8
Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease.默认模式网络tau蛋白可预测非典型早期阿尔茨海默病未来的临床衰退。
Brain. 2025 Apr 3;148(4):1329-1344. doi: 10.1093/brain/awae327.
9
Impact of diabetes on the progression of Alzheimer's disease via trajectories of amyloid-tau-neurodegeneration (ATN) biomarkers.糖尿病通过淀粉样蛋白- tau-神经变性(ATN)生物标志物轨迹对阿尔茨海默病进展的影响。
J Nutr Health Aging. 2025 Feb;29(2):100444. doi: 10.1016/j.jnha.2024.100444. Epub 2024 Dec 10.
10
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.

引用本文的文献

1
The early-onset Alzheimer's disease MRI signature: a replication and extension analysis in early-stage AD.早发型阿尔茨海默病的MRI特征:早期阿尔茨海默病的复制与扩展分析
Cereb Cortex. 2024 Dec 3;34(12). doi: 10.1093/cercor/bhae475.

本文引用的文献

1
The complex genetic architecture of Alzheimer's disease: novel insights and future directions.阿尔茨海默病的复杂遗传结构:新的见解和未来方向。
EBioMedicine. 2023 Apr;90:104511. doi: 10.1016/j.ebiom.2023.104511. Epub 2023 Mar 10.
2
Alzheimer's Disease: An Updated Overview of Its Genetics.阿尔茨海默病:遗传学的最新综述。
Int J Mol Sci. 2023 Feb 13;24(4):3754. doi: 10.3390/ijms24043754.
3
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
4
Genetically regulated expression in late-onset Alzheimer's disease implicates risk genes within known and novel loci.迟发性阿尔茨海默病中基因调控的表达提示了已知和新发病位中的风险基因。
Transl Psychiatry. 2021 Dec 6;11(1):618. doi: 10.1038/s41398-021-01677-0.
5
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.神经血管功能障碍和血管淀粉样蛋白积累是阿尔茨海默病的早期事件。
Metab Brain Dis. 2022 Jan;37(1):39-50. doi: 10.1007/s11011-021-00814-4. Epub 2021 Aug 18.
6
Effects of Alzheimer's and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer's Disease.阿尔茨海默病和血管病变对早发型及晚发型阿尔茨海默病结构连接性的影响
Front Neurosci. 2021 Feb 16;15:606600. doi: 10.3389/fnins.2021.606600. eCollection 2021.
7
Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?迟发性与非孟德尔早发性阿尔茨海默病:有区别吗?
Neurol Genet. 2020 Oct 6;6(5):e512. doi: 10.1212/NXG.0000000000000512. eCollection 2020 Oct.
8
Vascular Risk and β-Amyloid Are Synergistically Associated with Cortical Tau.血管风险与β-淀粉样蛋白与皮质 Tau 呈协同相关。
Ann Neurol. 2019 Feb;85(2):272-279. doi: 10.1002/ana.25399. Epub 2019 Jan 7.
9
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.tau蛋白病变和神经退行性变导致阿尔茨海默病的认知障碍。
Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243.
10
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.早发性和晚发性阿尔茨海默病中不同的 18F-AV-1451 tau PET 保留模式。
Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.